Metabolic syndrome and endothelin-1 mediated vasoconstrictor tone in overweight/obese adults

Metabolism: Clinical and Experimental

Volumn 63, Issue 7, 2014, Pages 951-956

  Rocha, Natalia G ^a,d   Templeton, Danielle L ^a   Greiner, Jared J ^a   Stauffer, Brian L ^a,b,c   Desouza, Christopher A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Blood flow; Endothelin 1; Metabolic syndrome

Indexed keywords

ENDOTHELIN 1; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM BLOOD FLOW; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; METABOLIC SYNDROME X; OBESITY; PLETHYSMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECEPTOR BLOCKING;

BLOOD FLOW; ENDOTHELIN-1; METABOLIC SYNDROME;

ADULT; AGED; BLOOD VESSELS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; ENDOTHELIN-1; FEMALE; FOREARM; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; PREHYPERTENSION; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 84902549248     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.04.007     Document Type: Article

References (39)

1. G.P. Van Guilder, G.L. Hoetzer, D.T. Smith, H.M. Irmiger, J.J. Greiner, and B.L. Stauffer et al. Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise Am J Physiol Endocrinol Metab 289 2005 E807 E813
2. B.R. Weil, C.M. Westby, G.P. Van Guilder, J.J. Greiner, B.L. Stauffer, and C.A. DeSouza Enhanced endothelin-1 system activity with overweight and obesity Am J Physiol Heart Circ Physiol 301 2011 H689 H695
3. H. Steinberg, H. Chaker, R. Leaming, A. Johnson, G. Brechtel, and A. Baron Obesity/insulin resistance is associated with endothelial dysfunction J Clin Invest 97 1996 2601 2610
4. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Arterioscler Thromb Vasc Biol 24 2004 e13 e18
5. E. Ingelsson, L.M. Sullivan, C.S. Fox, J.M. Murabito, E.J. Benjamin, and J.F. Polak et al. Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals Circulation 116 2007 375 384
6. H.M. Lakka, D.E. Laaksonen, T.A. Lakka, L.K. Niskanen, E. Kumpusalo, and J. Tuomilehto et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716
7. A. Onat Metabolic syndrome: nature, therapeutic solutions and options Expert Opin Pharmacother 12 2011 1887 1900
8. S. Mottillo, K.B. Filion, J. Genest, L. Joseph, L. Pilote, and P. Poirier et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
9. T. Miyauchi, and T. Masaki Pathophysiology of endothelin in the cardiovascular system Annu Rev Physiol 61 1999 391 415
10. R. Touyz, and E. Schiffrin Role of endothelin in human hypertension Can J Physiol Pharmacol 81 2003 533 541
11. Third Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
12. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation 1999 World Health Organization Geneva
13. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation Diabet Med 23 2006 469 480
14. K.J. Hunt, R.G. Resendez, K. Williams, S.M. Haffner, and M.P. Stern National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study Circulation 110 2004 1251 1257
15. C. Lorenzo, M. Okoloise, K. Williams, M.P. Stern, and S.M. Haffner The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study Diabetes Care 26 2003 3153 3159
16. T. Lohman, A. Roche, and R. Mortorell Athropometric standardization reference manual 1988 Human Kinetics Champaign, IL
17. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
18. C. Cardillo, C. Kilcoyne, M. Waclawiw, R. Cannon, and J. Panza Role of endothelin in the increased vascular tone of patients with essential hypertension Hypertension 33 1999 753 758
19. G.P. Van Guilder, C.M. Westby, J.J. Greiner, B.L. Stauffer, and C.A. DeSouza Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise Hypertension 50 2007 403 409
20. M. Dashwood, and J. Tsui Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade Atherosclerosis 160 2002 297 304
21. W. Haynes, F. Strachan, G. Gray, and D. Webb Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humans J Cardiovasc Pharmacol 26 1995 S40 S43
22. T. Masaki, S. Kimura, M. Yanagisawa, and K. Goto Molecular and cellular mechanism of endothelin regulation. Implications for vascular function Circulation 89 1991 1457 1468
23. T. Luscher, and M. Barton Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs Circulation 102 2000 2434 2440
24. K.J. Diehl, D.L. Templeton, J. Ma, B.R. Weil, J.J. Greiner, and B.L. Stauffer et al. Impaired fasting blood glucose is associated with increased endothelin-1 vasoconstrictor tone Atherosclerosis 229 2013 130 133
25. K. Mather, B. Mirzamohammadi, A. Lteif, H. Steinberg, and A. Baron Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes Diabetes 51 2002 3517 3523
26. B.R. Weil, B.L. Stauffer, J.J. Greiner, and C.A. DeSouza Prehypertension is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation in sedentary adults Am J Hypertens 24 2011 976 981
27. G.P. Van Guilder, G.L. Hoetzer, J.J. Greiner, B.L. Stauffer, and C.A. Desouza Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults Obesity (Silver Spring) 14 2006 2127 2131
28. J.N. Patel, A. Jager, C. Schalkwijk, R. Corder, J.A. Douthwaite, and J.S. Yudkin et al. Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release Clin Sci (Lond) 103 2002 409 415
29. D.M. Pollock, and J.S. Pollock Endothelin and oxidative stress in the vascular system Curr Vasc Pharmacol 3 2005 365 367
30. S. Verma, S.H. Li, M.V. Badiwala, R.D. Weisel, P.W. Fedak, and R.K. Li et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein Circulation 105 2002 1890 1896
31. M.M. Elgebaly, V. Portik-Dobos, K. Sachidanandam, D. Rychly, D. Malcom, and M.H. Johnson et al. Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes Vascul Pharmacol 47 2007 125 130
32. G.P. Van Guilder, G.L. Hoetzer, D.R. Dengel, B.L. Stauffer, and C.A. DeSouza Impaired endothelium-dependent vasodilation in normotensive and normoglycemic obese adult humans J Cardiovasc Pharmacol 47 2006 310 313
33. G.P. Van Guilder, B.L. Stauffer, J.J. Greiner, and C.A. Desouza Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists Am J Physiol Heart Circ Physiol 294 2008 H1685 H1692
34. B.L. Stauffer, C.M. Westby, J.J. Greiner, G.P. Van Guilder, and C.A. Desouza Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults Am J Physiol Regul Integr Comp Physiol 298 2010 R261 R265
35. S. Sharma, A.M. Malarcher, W.H. Giles, and G. Myers Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors Ethn Dis 14 2004 43 48
36. L.N. Pierre, and A.P. Davenport Endothelin receptor subtypes and their functional relevance in human small coronary arteries Br J Pharmacol 124 1998 499 506
37. L.N. Pierre, and A.P. Davenport Relative contribution of endothelin A and endothelin B receptors to vasoconstriction in small arteries from human heart and brain J Cardiovasc Pharmacol 31 Suppl 1 1998 S74 S76
38. C. Ihling, T. Szombathy, B. Bohrmann, M. Brockhaus, H.E. Schaefer, and B.M. Loeffler Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis Circulation 104 2001 864 869
39. J. Kelly, and J. Whitworth Endothelin-1 as a mediator in cardiovascular disease Clin Exp Pharmacol Physiol 26 1999 158 161